Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Which Is More Suitable For Aggressive Investors Index Fund Vs Target Date weighs volatility, potential upside, and suitability for growth-focused plans.
28,574 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
As mortgage workflows accelerate, industry insiders argue the real hurdle is trust, not velocity. This report examine...
In 2026, unicorns flush with cash face a new bottleneck: cap table gridlock. Despite record funding, ownership comple...
Valero Energy posts a 98% capacity utilization for 2025, expands its dividend, and exits California, fueling a fresh ...
A multi-decade rally faces a valuation crossroads as the CAPE gauge sits near historic highs. Here’s how years market...
Bitcoin remains the market benchmark as XRP pushes deeper into cross-border payments. Analysts weigh XRP's growth aga...
Investors are weighing whether lululemon stocks stage turnaround is still on the table. This guide breaks down the fa...
Rocket Lab’s Victus Haze mission signals a broader shift in the space industry—from launching payloads to delivering ...
Airbnb's Brian Chesky is reportedly exploring a dedicated AI lab, signaling his first major push into AI. The effort ...
The SEC has published a five-year plan prioritizing digital assets and blockchain, signaling a shift toward a formal ...
Markets are waiting for the actual reopening of the Strait of Hormuz, and the real deciders may be the shipping fleet...
Ripple wins preliminary approval to operate under MiCA in Luxembourg, but the path to a full MiCA license is far from...